Yale-NUS researchers discover drug cocktail that increases lifespan
A team of researchers led by Principal Investigator Dr Jan Gruber from Yale-NUS College has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.
The study, published in the peer-reviewed international journal Developmental Cell on 8 October 2018, lays crucial groundwork for further research into designing drug combinations that produce the same effect in mammals.
“Many countries in the world, including Singapore, are facing problems related to ageing populations,” said Dr Gruber, whose lab and research team made the discovery. “If we can find a way to extend healthy lifespan and delay ageing in people, we can counteract the detrimental effects of an ageing population, providing countries not only medical and economic benefits, but also a better quality of life for their people.”
Dr Gruber is an Assistant Professor of Science (Biochemistry) at Yale-NUS College and Assistant Professor at the Department of Biochemistry of the Yong Loo Lin School of Medicine at the National University of Singapore (NUS). The study was carried out by Dr Gruber’s research team in collaboration with researchers from the Singapore Lipidomics Incubator (SLING) at the Life Sciences Institute of NUS.
Dr Gruber’s team wanted to find out to what extent healthy lifespan could be extended by combining drugs targeting several pathways (underlying biological mechanisms) known to affect lifespan. For instance, the drug rapamycin is currently administered following organ transplants to prevent the body’s immune system from rejecting the transplanted organs, but previous experiments by other research groups showed that it extends the lifespan of many organisms, including the C. elegans worms, fruit flies and mice.
Dr Gruber’s team administered combinations of two or three compounds targeting different ageing pathways to C. elegans. Results showed that two drug pairs in particular extended the mean lifespan of the worms more than each of the drugs individually, and in combination with a third compound almost doubled mean lifespans. This effect is larger than any lifespan extension that has previously been reported for any drug intervention in adult animals.
The drug treatments had no adverse effect on the worm’s health. The researchers also discovered that across all ages, the treated worms were healthier and spend a larger percentage of their already extended lifespans in good health.
This is an important point for potential future human ageing interventions as increased health span, not just increased lifespan, would have significant medical and economic benefits. “We would benefit not only from having longer lives, but also spend more of those years free from age-related diseases like arthritis, cardiovascular disease, cancer, or Alzheimer’s disease,” Dr Gruber said. “These diseases currently require very expensive treatments, so the economic benefits of being healthier for longer would be enormous.” He cited a 2017 study that determined that if US citizens’ ageing rate was decreased by 20 percent, the US government would save US$7.1 trillion in public health costs over the next 50 years.
Dr Gruber’s lab also collaborated with Yale-NUS Associate Professor of Science (Life Science) Nicholas Tolwinski, who is also an Associate Professor with the Department of Biological Sciences at the NUS Faculty of Science, and found that a species of fruit flies (Drosophila melanogaster) treated with a similar drug cocktail also experienced significant lifespan extension. That two such evolutionarily-distinct organisms experience similar lifespan extensions suggests that the biological mechanisms that regulate these drug interactions on ageing are ancient, making it more likely that similar interactions between ageing pathways could be targeted in humans.
According to Dr Gruber, this study is a proof-of-principle, showing that pharmacological intervention targeting multiple ageing pathways is a promising strategy to slow ageing and dramatically extend healthy lifespan in adult animals.
The next steps for this research will focus on three large areas. The first will be to extend this approach with the aim of designing interventions even more effective than the ones developed in this study. The second area will involve determining the molecular and biological mechanisms of how the drugs interact to delay ageing and increase lifespan in order to develop computer models to simulate these interactions, allowing researchers to test thousands more combinations through computer modelling. The ultimate goal of this line of research would be to develop drug interventions safe enough slow ageing in humans, a goal that is also pursued by many other research teams around the world.
The Latest on: Lifespan
via Google News
The Latest on: Lifespan
- Lifespan Corp. understands that self-care is the best careon August 4, 2022 at 9:43 pm
PBN Healthiest Employers Awards 2022 5,000+ EMPLOYEES 3. Lifespan Corp. CEO (or equivalent): Arthur Sampson, Interim CEO and president Number of employees: 12,935 LIFESPAN CORP. OPERATES under the ...
- Can exposure to 'young' blood increase lifespan?on August 4, 2022 at 9:40 am
A new study in which young and old mice were surgically joined such that they shared blood circulation for three months showed that the old mice did not significantly benefit in terms of lifespan. In ...
- McCaughey: Democrats pushing lifespan reduction bill on Americanson August 3, 2022 at 9:52 pm
Democratic Sens. Chuck Schumer and Joe Manchin call their legislation the Inflation Reduction Act. Don’t let the title fool you. The bill cripples the ability of drug companies to develop ...
- LifeSpan Resources receives $11,000 Duke Energy grant for ride programon August 3, 2022 at 9:09 am
NEW ALBANY — LifeSpan Resources' fuel costs have doubled this summer compared to last year as the New Albany-based nonprofit offers transportation services for community members in need. The Duke ...
- The Democrats' Lifespan Reduction Acton August 2, 2022 at 9:03 pm
The bill cripples the ability of drug companies to develop new cures. It should be called the Lifespan Reduction Act. The bill empowers the federal government to impose price controls on top ...
- Inflation Reduction Act? Drug-price controls make Dems’ bill the Lifespan Reduction Acton August 2, 2022 at 7:27 pm
Democratic Sens. Chuck Schumer and Joe Manchin call their legislation the Inflation Reduction Act. Don’t let the title fool you. The bill cripples the ability of drug companies to develop new ...
- The Democrats' Lifespan Reduction Acton August 2, 2022 at 5:00 pm
Across the pond, Brits are demanding their next prime minister do something to reduce the U.K.'s notorious cancer death rates. But here in the U.S., ...
- Extra exercise could extend your lifespan and protect you from early death, study suggestson July 25, 2022 at 11:58 am
Getting more than five hours a week of exercise like walking could stave off serious health risks, according to a study of more than 100,000 people.
- Gene Regulation Might Be the Key to a Longer Lifespanon July 24, 2022 at 10:01 pm
Researchers from the University of Rochester who are interested in longevity genetics propose new targets to fight aging and age-related disorders. Mammals that age at vastly different rates have been ...
via Bing News